Psyence Biomedical Ltd. (NASDAQ:PBM) has a beta value of -0.33 and has seen 15.55 million shares traded in the recent trading session. The company, currently valued at $4.23M, closed the recent trade at $0.26 per share which meant it lost -$0.1 on the day or -28.51% during that session. The PBM stock price is -5496.15% off its 52-week high price of $14.55 and -3.85% below the 52-week low of $0.27. If we look at the company’s 10-day average daily trading volume, we find that it stood at 99810.0 shares traded. The 3-month trading volume is 2.46 million shares.
Psyence Biomedical Ltd. (NASDAQ:PBM) trade information
Sporting -28.51% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the PBM stock price touched $0.26 or saw a rise of 42.22%. Year-to-date, Psyence Biomedical Ltd. shares have moved -97.23%, while the 5-day performance has seen it change -41.82%. Over the past 30 days, the shares of Psyence Biomedical Ltd. (NASDAQ:PBM) have changed -50.41%. Short interest in the company has seen 0.69 million shares shorted with days to cover at 0.12.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
PBM Dividends
Psyence Biomedical Ltd. is expected to release its next earnings report in October this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
